Intra-Cellular Therapies
Barbara C. Khan is an accomplished clinical development professional with extensive experience in the pharmaceutical industry. Currently serving as Executive Director of Clinical Development at Intra-Cellular Therapies since August 2022, Barbara has held significant leadership roles, including Senior Director of Clinical Development at Palladio Biosciences, Executive Director of Neuroscience Development at AbbVie, and multiple positions at Allergan and Forest Laboratories. Barbara's educational background includes a Master of Public Health in Epidemiology from Harvard T.H. Chan School of Public Health, a Bachelor of Arts from Cornell University, a Data Analytics Certificate from Cornell University, and a Master of Science from Drexel University College of Medicine.
This person is not in any teams
This person is not in any offices
Intra-Cellular Therapies
2 followers
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.